<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38097574</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2059-3635</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Signal transduction and targeted therapy</Title><ISOAbbreviation>Signal Transduct Target Ther</ISOAbbreviation></Journal><ArticleTitle>Long-COVID-19: the persisting imprint of SARS-CoV-2 infections on the innate immune system.</ArticleTitle><Pagination><StartPage>460</StartPage><MedlinePgn>460</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">460</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41392-023-01717-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boes</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Translational Immunology and Department of Pediatric Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falter-Braun</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Munich, Neuherberg, Germany. pascal.falter-braun@helmholtz-munich.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbe-Host Interactions, Faculty of Biology, Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen, Planegg-Martinsried, Germany. pascal.falter-braun@helmholtz-munich.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>101003633</GrantID><Agency>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</Agency><Country/></Grant><Grant><GrantID>01EA1803</GrantID><Agency>Bundesministerium f&#xfc;r Bildung, Wissenschaft, Forschung und Technologie (Federal Ministry for Education, Science, Research and Technology)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Signal Transduct Target Ther</MedlineTA><NlmUniqueID>101676423</NlmUniqueID><ISSNLinking>2059-3635</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>17</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>15</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>14</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38097574</ArticleId><ArticleId IdType="pmc">PMC10721820</ArticleId><ArticleId IdType="doi">10.1038/s41392-023-01717-9</ArticleId><ArticleId IdType="pii">10.1038/s41392-023-01717-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cheong JG, et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. 2023;186:3882&#x2013;3902 e3824. doi: 10.1016/j.cell.2023.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.07.019</ArticleId><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 2020;20:375&#x2013;388. doi: 10.1038/s41577-020-0285-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0285-6</ArticleId><ArticleId IdType="pmc">PMC7186935</ArticleId><ArticleId IdType="pubmed">32132681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto T, Kang S. IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19. Annu Rev. Immunol. 2022;40:323&#x2013;348. doi: 10.1146/annurev-immunol-101220-023458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-101220-023458</ArticleId><ArticleId IdType="pubmed">35113729</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>